Apr 27, 2016 7:00 am EDT NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
Mar 1, 2016 7:00 am EST NeoGenomics Reports Record Revenue of $27.2 Million and Record Adjusted EBITDA of $2.9 Million in Fourth Quarter, Driven by Strong Volume Gains
Jan 26, 2016 7:00 am EST NeoGenomics Schedules its Q4 2015 and Full Year 2015 Earnings Release for March 1, 2016
Dec 8, 2015 7:00 am EST NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors
Oct 29, 2015 7:00 am EDT NeoGenomics Reports Revenue of $25.1 Million and Record Adjusted EBITDA of $2.8 Million Driven by a 25% Increase in Test Volume in the Third Quarter of 2015
Oct 28, 2015 7:08 pm EDT NeoGenomics Amends Strategic Alliance Agreement with Covance Central Laboratory Services
